These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 26276971

  • 1. Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.
    Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G, Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.
    J Rheumatol; 2015 Oct; 42(10):1786-93. PubMed ID: 26276971
    [Abstract] [Full Text] [Related]

  • 2. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A, Zipfel PF, Bokarewa MI, Sturfelt G, Jönsen A, Nilsson SC, Hillarp A, Saxne T, Trouw LA, Blom AM.
    Arthritis Res Ther; 2012 Aug 15; 14(4):R185. PubMed ID: 22894814
    [Abstract] [Full Text] [Related]

  • 3. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L, Markovic O, Marisavljevic D, Elezovic I, Ilijevski N, Stanisavljevic N.
    Lupus; 2012 Mar 15; 21(3):338-45. PubMed ID: 21993381
    [Abstract] [Full Text] [Related]

  • 4. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I, Levi Y, Godard G, Shoenfeld Y.
    Harefuah; 2001 Jun 15; 140(6):495-500, 565. PubMed ID: 11420848
    [Abstract] [Full Text] [Related]

  • 5. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
    Chwalińska-Sadowska H, Meissner M, Wudarski M, Zabek J, Wojciechowska B.
    Pol Arch Med Wewn; 2006 May 15; 115(5):401-6. PubMed ID: 17195351
    [Abstract] [Full Text] [Related]

  • 6. Low prevalence of antiannexin A5 antibodies in unprovoked venous thrombosis.
    Ho WK, Rigano J.
    Int J Lab Hematol; 2021 Oct 15; 43(5):1225-1228. PubMed ID: 33586909
    [Abstract] [Full Text] [Related]

  • 7. Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome.
    Nakamura H, Oku K, Ogata Y, Ohmura K, Yoshida Y, Kitano E, Fujieda Y, Kato M, Bohgaki T, Amengual O, Yasuda S, Fujimura Y, Seya T, Atsumi T.
    Thromb Res; 2018 Apr 15; 164():63-68. PubMed ID: 29494857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
    Nascimento NM, Bydlowski SP, Soares RP, de Andrade DC, Bonfá E, Seguro LP, Borba EF.
    J Thromb Thrombolysis; 2015 Oct 15; 40(3):374-8. PubMed ID: 25638331
    [Abstract] [Full Text] [Related]

  • 12. Transcranial Doppler findings in antiphospholipid syndrome.
    Ricarte IF, Dutra LA, Barsottini OGP, Souza AWS, Andrade DCO, Mangueira C, Silva GS.
    Lupus; 2019 Apr 15; 28(4):483-491. PubMed ID: 30755144
    [Abstract] [Full Text] [Related]

  • 13. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun 15; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
    Stojanovich L, Djokovic A, Kontic M.
    Clin Exp Rheumatol; 2015 Jun 15; 33(4):531-6. PubMed ID: 26088955
    [Abstract] [Full Text] [Related]

  • 15. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Tonello M, Bontadi A, Salvan E, Banzato A, Pengo V, Punzi L.
    Lupus; 2012 Jun 15; 21(7):787-9. PubMed ID: 22635234
    [Abstract] [Full Text] [Related]

  • 16. The family history of patients with primary or secondary antiphospholipid syndrome (APS).
    Weber M, Hayem G, DeBandt M, Palazzo E, Roux S, Kahn MF, Meyer O.
    Lupus; 2000 Jun 15; 9(4):258-63. PubMed ID: 10866096
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A, Swadźba J, Iwaniec T, Sanak M, Dziedzina S, Ćmiel A, Musiał J.
    Thromb Res; 2014 Feb 15; 133(2):173-6. PubMed ID: 24321419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.
    Lupus; 2010 May 15; 19(6):711-6. PubMed ID: 20064910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.